{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:06:40Z","timestamp":1789711600125,"version":"4.0.1"},"reference-count":33,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T00:00:00Z","timestamp":1786838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Hexal AG"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/14712598.2026.2703142","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T06:13:38Z","timestamp":1786688018000},"page":"1009-1019","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Patient-reported satisfaction following a switch from reference denosumab to biosimilar denosumab: real-world data from a Canadian patient survey"],"prefix":"10.1080","volume":"26","author":[{"given":"Aliya A.","family":"Khan","sequence":"first","affiliation":[{"name":"McMaster University","place":["Hamilton, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Allard-Chamard","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine et des Sciences de la Sant\u00e9 de l\u2019Universit\u00e9 de Sherbrooke et Centre de Recherche du CHUS","place":["Sherbrooke, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikameh","family":"Kazem","sequence":"additional","affiliation":[{"name":"University of British Columbia","place":["Vancouver, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Khan","sequence":"additional","affiliation":[{"name":"Bone Research and Education Centre","place":["Oakville, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanu N.","family":"Ruban","sequence":"additional","affiliation":[{"name":"University of Toronto","place":["Toronto, Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,8,16]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2022.2141483"},{"key":"e_1_3_8_4_1","unstructured":"Porter JL Varacallo MA. Osteoporosis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Mar 21. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441901\/"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.882241"},{"key":"e_1_3_8_6_1","unstructured":"Osteoporosis Canada. 2022 osteoporosis Canada facts and stats. 2022 [cited 2025 Aug 13. Available from: https:\/\/osteoporosis.ca\/wp-content\/uploads\/2022-Osteoporosis-Canada-Facts-and-Stats_Web.pdf"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1456796"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad496"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05951-1"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027049"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2024.2386365"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00803"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2019-00221"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.4158\/GL-2020-0524SUPPL"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogc.2021.09.013"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-024-01094-9"},{"key":"e_1_3_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01936-y"},{"key":"e_1_3_8_18_1","unstructured":"FDA. Overview for health care professionals. 2024 [cited 2025 Aug 13. Available from: https:\/\/www.fda.gov\/drugs\/biosimilars\/overview-health-care-professionals"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph17020235"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.211478"},{"key":"e_1_3_8_21_1","unstructured":"Joszt L. More Canadian jurisdictions implement mandatory biosimilar switching policies. AJMC. 2023 [cited 2026 May 28]. Available from: https:\/\/www.ajmc.com\/view\/more-canadian-jurisdictions-implement-mandatory-biosimilar-switching-policies"},{"key":"e_1_3_8_22_1","unstructured":"Canadian Biosimilars Forum. About biosimilars and switching. 2021 [cited 2026 May 28. Available from: https:\/\/www.canadianbiosimilarsforum.ca\/key-facts"},{"key":"e_1_3_8_23_1","unstructured":"Health Canada. Approval of Jubbonti. 2024 [cited 2025 Aug 25]. Available from: https:\/\/dhpp.hpfb-dgpsa.ca\/dhpp\/resource\/103418"},{"key":"e_1_3_8_24_1","unstructured":"FDA. Jubbonti\u00ae (denosumab) US prescribing information. 2024 [cited 2025 Sep 2]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761362s000lbl.pdf"},{"key":"e_1_3_8_25_1","unstructured":"EMA. Jubbonti\u00ae (denosumab). Summary of product characteristics. 2024 [cited 2025 Sep 2] Available from: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/jubbonti"},{"key":"e_1_3_8_26_1","unstructured":"Ontario Ministry of Health. Biosimilar policy - denosumab. 2024 [cited 2026 May 28]. Available from: https:\/\/www.ontario.ca\/files\/2024-11\/moh-executive-officer-notice-en-2024-11-21.pdf"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S104891"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-025-00727-z"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-024-00681-2"},{"key":"e_1_3_8_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24012"},{"key":"e_1_3_8_31_1","unstructured":"FDA. Biosimilar product information. 2024 [cited 2025 Aug 13. Available from: https:\/\/www.fda.gov\/drugs\/biosimilars\/biosimilar-product-information"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-023-00616-3"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0085-z"},{"key":"e_1_3_8_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-019-4680-2"},{"key":"e_1_3_8_35_1","unstructured":"IQVIA. Compuscript TRX September 2025. 2025."}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2703142","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14712598.2026.2703142","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14712598.2026.2703142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:23:40Z","timestamp":1789709020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14712598.2026.2703142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,16]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/14712598.2026.2703142"],"URL":"https:\/\/doi.org\/10.1080\/14712598.2026.2703142","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iebt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-06-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}